Prana commences research collaboration with Takeda for the treatment of Parkinson’s disease gastrointestinal neuropathology
PBT434, Prana’s lead drug in preclinical development for movement disorders, to be profiled in collaborative venture
Scientific Journal Acta Neuropathologica publishes pre-clinical data
Prana AGM webcast
Receive regular updates from Prana Biotechnology by entering your details below and clicking "Subscribe"